Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289731461> ?p ?o ?g. }
- W4289731461 endingPage "1623" @default.
- W4289731461 startingPage "1623" @default.
- W4289731461 abstract "Flavonoids are polyphenolic compounds largely present in fruits and vegetables possessing antioxidant properties, anti-inflammatory and antibacterial activities. Their use in clinical practice is very poor due to their low bioavailability, susceptibility to oxidation and degradation. Moreover, their slight solubility in biological fluids and a consequent low dissolution rate leads to an irregular absorption from solid dosage forms, even though, anti-inflammatory formulations could be used as support for several disease treatment, i.e. the COVID-19 syndrome. To improve flavonoid bioavailability particle size of the powder can be reduced to make it breathable and to promote the absorption in the lung tissues. Supercritical fluid based antisolvent technique has been used to produce naringin particles, with size, shape and density as well as free flowing properties able to fit inhalation needs. The dried particles are produced with the removal of the solvent at lower temperatures compared to the most used traditional micronization processes, such as spray drying. The best breathable fraction for naringin particles is obtained for particles with a d50~7 µm manufactured at 35 °C-150 bar and at 60 °C-130 bar, corresponding to 32.6% and 36.7% respectively. The powder is produced using a high CO2 molar fraction (0.99) that assure a better removal of the solvent. NuLi-1 cell line of immortalised bronchial epithelial cells adopted to evaluate powder cytotoxicity indicated after 24 h absence of toxicity at concentration of 25 µM." @default.
- W4289731461 created "2022-08-04" @default.
- W4289731461 creator A5002083498 @default.
- W4289731461 creator A5005669717 @default.
- W4289731461 creator A5047165941 @default.
- W4289731461 creator A5052157527 @default.
- W4289731461 creator A5052967488 @default.
- W4289731461 creator A5076775300 @default.
- W4289731461 creator A5089201408 @default.
- W4289731461 date "2022-08-03" @default.
- W4289731461 modified "2023-09-26" @default.
- W4289731461 title "Supercritical Antisolvent Technique for the Production of Breathable Naringin Powder" @default.
- W4289731461 cites W1869177231 @default.
- W4289731461 cites W1967468829 @default.
- W4289731461 cites W1968616573 @default.
- W4289731461 cites W1974818937 @default.
- W4289731461 cites W1975132504 @default.
- W4289731461 cites W1977947871 @default.
- W4289731461 cites W1978881174 @default.
- W4289731461 cites W1988987582 @default.
- W4289731461 cites W1990168733 @default.
- W4289731461 cites W1990880855 @default.
- W4289731461 cites W1991564000 @default.
- W4289731461 cites W1993458540 @default.
- W4289731461 cites W1998867182 @default.
- W4289731461 cites W1998987361 @default.
- W4289731461 cites W2000066355 @default.
- W4289731461 cites W2000175714 @default.
- W4289731461 cites W2007025545 @default.
- W4289731461 cites W2009080092 @default.
- W4289731461 cites W2020621217 @default.
- W4289731461 cites W2026874549 @default.
- W4289731461 cites W2039930671 @default.
- W4289731461 cites W2044982045 @default.
- W4289731461 cites W2045869030 @default.
- W4289731461 cites W2046802172 @default.
- W4289731461 cites W2047384614 @default.
- W4289731461 cites W2048259701 @default.
- W4289731461 cites W2054193309 @default.
- W4289731461 cites W2058888350 @default.
- W4289731461 cites W2064039741 @default.
- W4289731461 cites W2080378727 @default.
- W4289731461 cites W2085799370 @default.
- W4289731461 cites W2087821286 @default.
- W4289731461 cites W2089438001 @default.
- W4289731461 cites W2094594665 @default.
- W4289731461 cites W2109335148 @default.
- W4289731461 cites W2134732376 @default.
- W4289731461 cites W2144868623 @default.
- W4289731461 cites W2326385769 @default.
- W4289731461 cites W2340509144 @default.
- W4289731461 cites W246064223 @default.
- W4289731461 cites W2465525959 @default.
- W4289731461 cites W2489021876 @default.
- W4289731461 cites W2514937930 @default.
- W4289731461 cites W2530708261 @default.
- W4289731461 cites W2587128956 @default.
- W4289731461 cites W2599968024 @default.
- W4289731461 cites W2758199285 @default.
- W4289731461 cites W2888020968 @default.
- W4289731461 cites W2912118776 @default.
- W4289731461 cites W3009980084 @default.
- W4289731461 cites W3041809389 @default.
- W4289731461 cites W3109073121 @default.
- W4289731461 cites W3122670386 @default.
- W4289731461 cites W3133314732 @default.
- W4289731461 cites W4206449938 @default.
- W4289731461 cites W4281863382 @default.
- W4289731461 cites W852778832 @default.
- W4289731461 cites W879093394 @default.
- W4289731461 doi "https://doi.org/10.3390/pharmaceutics14081623" @default.
- W4289731461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36015250" @default.
- W4289731461 hasPublicationYear "2022" @default.
- W4289731461 type Work @default.
- W4289731461 citedByCount "3" @default.
- W4289731461 countsByYear W42897314612022 @default.
- W4289731461 countsByYear W42897314612023 @default.
- W4289731461 crossrefType "journal-article" @default.
- W4289731461 hasAuthorship W4289731461A5002083498 @default.
- W4289731461 hasAuthorship W4289731461A5005669717 @default.
- W4289731461 hasAuthorship W4289731461A5047165941 @default.
- W4289731461 hasAuthorship W4289731461A5052157527 @default.
- W4289731461 hasAuthorship W4289731461A5052967488 @default.
- W4289731461 hasAuthorship W4289731461A5076775300 @default.
- W4289731461 hasAuthorship W4289731461A5089201408 @default.
- W4289731461 hasBestOaLocation W42897314611 @default.
- W4289731461 hasConcept C118419359 @default.
- W4289731461 hasConcept C125287762 @default.
- W4289731461 hasConcept C127413603 @default.
- W4289731461 hasConcept C147789679 @default.
- W4289731461 hasConcept C155574463 @default.
- W4289731461 hasConcept C159985019 @default.
- W4289731461 hasConcept C178790620 @default.
- W4289731461 hasConcept C181389837 @default.
- W4289731461 hasConcept C185592680 @default.
- W4289731461 hasConcept C187530423 @default.
- W4289731461 hasConcept C192562407 @default.
- W4289731461 hasConcept C2777335409 @default.